17,520 resources
By Version
By Realm
Start Prev Rows 8000 - 8200 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Source(s) |
---|---|---|---|---|---|---|---|---|---|
hl7.terminology | R5 | v3-EmergencyPharmacySupplyType | EmergencyPharmacySupplyType | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-RoleClassActiveIngredient | RoleClassActiveIngredient | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ActClassFinancialAdjudication | ActClassFinancialAdjudication | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ActRelationshipMatchesTrigger | ActRelationshipMatchesTrigger | active | 2014-03 | uv | tho | ||
hl7.fhir.uv.vhdir | R4 | digitalcertificatetrustframework | VhDir Digital Certificate Trust Framework Value Set | trial-use | 2 | pa | 2018-02 | uv | fhir |
hl7.terminology | R5 | v3-LiquidLiquidEmulsion | LiquidLiquidEmulsion | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-xMedicine | x_Medicine | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-xAdministeredSubstance | x_AdministeredSubstance | active | 2014-03 | uv | tho | ||
hl7.fhir.uv.cpg | R4 | cpg-activity-type-vs | CPG Activity Type Value Set | active | cds | 2024-11 | uv | fhir | |
hl7.fhir.uv.cpg | R4 | cpg-casefeature-pertinence-vs | CPG Case Feature Pertinence Value Set | active | cds | 2024-11 | uv | fhir | |
hl7.fhir.uv.cpg | R4 | cpg-casefeature-type-vs | CPG Case Feature Type Value Set | active | cds | 2024-11 | uv | fhir | |
hl7.terminology | R5 | v3-EntityClassHolder | EntityClassHolder | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-QualityMeasureSectionType | QualityMeasureSectionType | active | 2014-03 | uv | loinc | ||
ca.on.ppr.r4 | R4 | ProviderRoleAffiliationType-provider | ProviderAffiliationType | draft | |||||
hl7.terminology | R5 | v3-ActClassAccession | ActClassAccession | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-LocalRemoteControlState | LocalRemoteControlState | active | 2014-03 | uv | tho | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.1.11.12199 | LanguageAbilityProficiency | active | 2024-06 | us | tho | ||
hl7.terminology | R5 | v3-LanguageAbilityProficiency | LanguageAbilityProficiency | active | 2014-03 | uv | tho | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.1.11.12249 | LanguageAbilityMode | active | 2024-06 | us | tho | ||
hl7.terminology | R5 | v3-LanguageAbilityMode | LanguageAbilityMode | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-DrugEntity | Drug Entity | active | 2022-10 | uv | tho | ||
hl7.terminology | R5 | v3-EntityCode | EntityCode | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-materialForm | materialForm | retired | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-GenderStatus | GenderStatus | active | 2014-03 | uv | tho | ||
fhir.nigeriaImmunization | R4 | IMMZD16-ValueSet | IMMZD16-ValueSet for AEFI Treatment | draft | 2025-05 | us | internal | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.61 | Care Model | active | 2024-06 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.1.11.19185 | Religious Affiliation | active | 2024-06 | us | tho | ||
hl7.fhir.eu.imaging-manifest-r5 | R5 | periods-of-life-value-set | Periods of Life | draft | 2025-07 | eu | sct | ||
hl7.fhir.eu.imaging-r5 | R5 | periods-of-life-value-set | Periods of Life | draft | 2025-07 | eu | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.7.1 | SupportedFileFormats | active | 2024-06 | us | tho | ||
hl7.fhir.us.spl | R5 | valueset-AllNDCProducts | All NDC Products | trial-use | 1 | brr | 2025-07 | us | ndc |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.1 | Pregnancy Status | active | 2023-08 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.10 | Pap Smear Tests | active | 2023-07 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.11 | HIV Tests | active | 2023-07 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.12 | Human Papilloma Virus Tests | active | 2023-07 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.13 | Chlamydia Trachomatis Tests | active | 2023-07 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.14 | Neisseria Gonorrhoeae Tests | active | 2023-07 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.17 | Contraceptive Type | active | 2023-07 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.18 | Contraception Not Used Reason | active | 2023-07 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.209 | Yes and No Answers | active | 2023-07 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.21 | Contraceptive Provision Method | active | 2023-07 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.210 | Pap Smear Results | active | 2023-07 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.211 | Contraceptive discussion | active | 2023-08 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.24 | Clinical Provider Role | active | 2023-07 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.29 | Insurance Coverage Type | active | 2023-07 | us | |||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.3 | Organism Detection | active | 2023-07 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.31 | English Proficiency | active | 2023-07 | us | sct | ||
hl7.fhir.us.vitals | R4 | LowOnlyNumericResultIntVS | Low Only Numeric Result Interpretation value set | draft | 2024-10 | us | tho | ||
nhsd.assets.stu3 | R3 | ValueSet-PEC-ExemptionType-1 | PEC Exemption Type | draft | 2017-12 | ||||
nhsd.assets.stu3 | R3 | ValueSet-PersonRelationshipType-1 | Person Relationship Type | draft | 2017-10 | ||||
nhsd.assets.stu3 | R3 | ITK-PatientAllergyChangeType-1 | Patient Allergy Change Type | draft | 2017-12 | ||||
nhsd.assets.stu3 | R3 | ITK-PatientMedicationChangeType-1 | Patient Medication Change Type | draft | 2017-09 | ||||
nhsd.assets.stu3 | R3 | ITK-ConditionFlag-1 | ITK Condition Flag | draft | 2018-04 | ||||
nhsd.assets.stu3 | R3 | ValueSet-eRS-AdditionalRequirementType-1 | eRS Additional Requirement Type | draft | |||||
nhsd.assets.stu3 | R3 | ITK-RecipientType-1 | ITK Recipient Type | active | 2018-08 | ||||
nhsd.assets.stu3 | R3 | ITK-BusAcknowledgement-1 | ITK Business Acknowledgement | draft | 2017-09 | ||||
nhsd.assets.stu3 | R3 | ITK-InfAcknowledgement-1 | ITK Infrastructure Acknowledgement | draft | 2017-12 | ||||
nhsd.assets.stu3 | R3 | ITK-ResponseCodes-1 | ITK Response Codes | active | 2018-08 | ||||
nhsd.assets.stu3 | R3 | eRS-BookableType-1 | eRS Bookable Type | draft | |||||
nhsd.assets.stu3 | R3 | eRS-ClinicType-1 | eRS Clinic Type | draft | |||||
uk.nhsdigital.r4.test | R4 | d2a51dd0-9e86-4cea-9064-077637cb79b7 | ERSAppointmentCancellationReason | draft | |||||
uk.nhsdigital.r4.test | R4 | d2a51dd0-9e86-4cea-9064-077637cb79b7 | ERSReferralState | draft | |||||
uk.nhsdigital.r4.test | R4 | bb928767-263e-457c-9ee0-1a3d239ddc10 | ERSClinicType | draft | |||||
nhsd.assets.stu3 | R3 | eRS-CommissioningProvisioning-1 | eRS Commissioning Provisioning | draft | |||||
nhsd.assets.stu3 | R3 | eRS-CommissioningType-1 | eRS Commissioning Type | draft | |||||
nhsd.assets.stu3 | R3 | ITK-MessageEvent-2 | ITK Message Event | active | 2018-08 | ||||
nhsd.assets.stu3 | R3 | eRS-GenderTreated-1 | eRS Gender Treated | draft | |||||
nhsd.assets.stu3 | R3 | ValueSet-eRS-OrganisationType-1 | eRS Organisation Type | draft | |||||
NHSDigital.FHIR.STU3 | R3 | eRS-ReferralCancellationReason-1 | eRS Referral Cancellation Reason | active | 2022-03 | ||||
nhsd.assets.stu3 | R3 | eRS-ReferralTreatmentMissingReason-1 | eRS Referral Treatment Missing Reason | draft | |||||
nhsd.assets.stu3 | R3 | eRS-RequestFlowType-1 | eRS Request Flow Type | draft | |||||
nhsd.assets.stu3 | R3 | eRS-FetchOutcomeType-1 | DO NOT USE - eRS Fetch Outcome Type | retired | |||||
nhsd.assets.stu3 | R3 | eRS-Specialty-1 | eRS Referral Type | active | |||||
nhsd.assets.stu3 | R3 | eRS-Specialty-1 | eRS Specialty | draft | |||||
nhsd.assets.stu3 | R3 | eRS-ReferralRequestStatus-1 | eRS Referral Request Status | draft | |||||
nhsd.assets.stu3 | R3 | ValueSet-eRS-AppointmentType-1 | eRS Appointment Type | draft | |||||
nhsd.assets.stu3 | R3 | eRS-CapacityAlert-1 | eRS Capacity Alert | draft | |||||
nhsd.assets.stu3 | R3 | eRS-CapacityStatus-1 | eRS Capacity Status | draft | |||||
nhsd.assets.stu3 | R3 | eRS-RequestType-1 | eRS Request Type | draft | |||||
nhsd.assets.stu3 | R3 | eRS-ServiceSearch-SortBy-1 | eRS ServiceSearch Sort By - DO NOT USE | retired | |||||
nhsd.assets.stu3 | R3 | eRS-SortBy-1 | eRS Sort By | draft | |||||
nhsd.assets.stu3 | R3 | eRS-IWT-1 | eRS Indicative Wait Time | draft | |||||
nhsd.assets.stu3 | R3 | eRS-ReferralLetterIntention-1 | eRS Referral Letter Intention | draft | |||||
hl7.terminology | R5 | v3-ParticipationAuthenticator | ParticipationAuthenticator | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ParticipationLegalAuthenticator | ParticipationLegalAuthenticator | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-SwabDrugForm | SwabDrugForm | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-PersonalAndLegalRelationshipRoleType | PersonalAndLegalRelationshipRoleType | active | 2023-06 | uv | tho | ||
de.basisprofil.r4 | R4 | valueset-wg14 | WG14 ValueSet | active | 2025-06 | ||||
HIE2.packages | R4 | results-laboratory-blood-abo-rh-grp-gps-uv-ips | Results Laboratory ABO+RH Group (GPS) - IPS | active | 2022-01 | uv | sct | ||
hl7.fhir.us.registry-protocols | R4 | LesionComplexity | Complexity of the Lesion | active | cic | 2023-11 | us | fhir | |
hl7.fhir.us.registry-protocols | R4 | CABGIndication | CABG Indication | active | cic | 2023-11 | us | fhir | |
hl7.fhir.us.medmorph | R4 | us-ph-computable-valueset-example | US Public Health Computable ValueSet Example | draft | 2022-07 | us | |||
hl7.fhir.us.ecr | R4 | us-ph-computable-valueset-example | US Public Health Computable ValueSet Example | draft | 2022-05 | us | |||
hl7.fhir.us.ph-library | R4 | us-ph-valueset-computable-example | US Public Health ValueSet - Computable Example | draft | 2022-07 | us | |||
hl7.fhir.us.breast-radiology | R4 | rde1562-laterality-from-landmark | RDE1562 Laterality from landmark | draft | 2022-10 | us | fhir | ||
hl7.fhir.us.breast-radiology | R4 | rde1565-type | RDE1565 Type | draft | 2022-10 | us | fhir | ||
hl7.fhir.us.breast-radiology | R4 | rde1568-distribution | RDE1568 Distribution | draft | 2022-12 | us | fhir | ||
hl7.fhir.us.breast-radiology | R4 | rde1571-associated-features | RDE1571 Associated features | draft | 2022-11 | us | fhir | ||
hl7.fhir.us.breast-radiology | R4 | rde1576-shape | RDE1576 Shape | draft | 2022-11 | us | fhir | ||
hl7.fhir.us.breast-radiology | R4 | rde1577-type | RDE1577 Type | draft | 2022-10 | us | fhir | ||
hl7.fhir.us.breast-radiology | R4 | rde1578-density | RDE1578 Density | draft | 2022-10 | us | fhir | ||
hl7.fhir.us.breast-radiology | R4 | rde1579-margin | RDE1579 Margin | draft | 2022-10 | us | fhir | ||
hl7.fhir.us.breast-radiology | R4 | rde1580-orientation | RDE1580 Orientation | draft | 2022-10 | us | fhir | ||
hl7.fhir.us.breast-radiology | R4 | rde1586-assessment-category | RDE1586 Assessment category | draft | 2022-11 | us | fhir | ||
hl7.fhir.us.breast-radiology | R4 | rde1587-breast-composition-category | RDE1587 Breast composition category | draft | 2022-11 | us | fhir | ||
hl7.fhir.us.breast-radiology | R4 | rde1588-breast-laterality | RDE1588 Breast laterality | draft | 2022-11 | us | fhir | ||
hl7.fhir.us.breast-radiology | R4 | rde1589-implant-presence | RDE1589 Implant presence | draft | 2022-11 | us | fhir | ||
hl7.fhir.us.breast-radiology | R4 | rde1590-prior-mastectomy | RDE1590 Prior mastectomy | draft | 2022-11 | us | fhir | ||
hl7.fhir.us.breast-radiology | R4 | rde1602-type | RDE1602 Type | draft | 2022-12 | us | fhir | ||
hl7.fhir.it.lab-report | R4 | aifa-aic | AIFA AIC | active | 2024-03 | it | internal | ||
hl7.fhir.it.terminology | R4 | aifa-ge | AIFA Gruppo di Equivalenza | active | 2025-06 | it | internal | ||
hl7.org.nz.fhir.ig.formulary | R4B | atc-code | ATC codes | active | 2025-07 | nz | atc | ||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.20.5.4--20200901000000 | AanduidingBijNummerCodelijst | active | nl | oid | |||
hl7.terminology | R5 | verificationresult-can-push-updates | Can-push-updates | active | pa | 2024-04 | uv | tho | |
ca.on.oh-olis | R4 | olis-InterpretationProvider | Interpretation | active | tho | ||||
hl7.fhir.us.breast-radiology | R4 | rde1556-presence | RDE1556 Presence | draft | 2022-12 | us | fhir | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.34 | AbnormalityOfGaitAndMobility | active | 2021-07 | us | icd | ||
HIE2.packages | R4 | absent-or-unknown-allergies-uv-ips | Absent or Unknown Allergies - IPS | active | 2022-01 | uv | fhir | ||
hl7.cda.uv.ips | R4 | 2.16.840.1.113883.11.22.61--20180127221947 | Absent or Unknown Devices | draft | 2024-08 | uv | fhir | ||
HIE2.packages | R4 | absent-or-unknown-immunizations-uv-ips | Absent or Unknown Immunization - IPS | active | 2022-01 | uv | fhir | ||
HIE2.packages | R4 | absent-or-unknown-medications-uv-ips | Absent or Unknown Medication - IPS | active | 2022-01 | uv | fhir | ||
HIE2.packages | R4 | absent-or-unknown-problems-uv-ips | Absent or Unknown Problems - IPS | active | 2022-01 | uv | fhir | ||
hl7.eu.fhir.pcsp | R4 | absent-or-unknown-procedures-uv-ips | Absent or Unknown Procedures - IPS | trial-use | 2 | 2022-11 | eu | fhir | |
hl7.fhir.us.mcode | R4 | mcode-tumor-size-units-vs | Tumor Size Units Value Set | active | 3 | cic | 2025-02 | us | ucum |
hl7.terminology | R5 | cql-access-modifier | CQL Access Modifier | draft | cds | 2024-02 | uv | tho | |
hl7.terminology | R5 | v3-ActEncounterAccommodationCode | ActEncounterAccommodationCode | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-AcknowledgementCondition | AcknowledgementCondition | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-AcknowledgementType | AcknowledgementType | active | 2014-03 | uv | tho | ||
ee.hl7.fhir.base.r5 | R5 | ee-act-priority | Act Priority | draft | 2023-08 | ee | tho | ||
ee.fhir.terminology | R5 | act-priority | Act Priority | active | 2025-06 | ee | tho | ||
hl7.terminology | R5 | v3-ActConsentDirectiveType | ActConsentDirectiveType | active | sec | 2019-03 | uv | tho | |
hl7.terminology | R5 | v3-ActConsentDirective | ActConsentDirective | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ActPrivacyLaw | ActPrivacyLaw | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ActPrivacyPolicy | ActPrivacyPolicy | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ActInformationSensitivityPolicy | ActInformationSensitivityPolicy | active | 2014-03 | uv | tho | ||
hl7.cda.uv.ips | R4 | 2.16.840.1.113883.11.22.22--20170502000000 | ActStatusActiveCompletedAbortedCancelled | draft | 2024-08 | uv | tho | ||
hl7.cda.uv.ips | R4 | 2.16.840.1.113883.11.22.12--20170330000000 | ActStatusActiveCompletedAbortedSuspended | draft | 2024-08 | uv | tho | ||
ch.fhir.ig.ch-term | R4 | ActSubstanceAdminSubstitutionCode | ActSubstanceAdminSubstitutionCode | active | 2025-05 | ch | tho | ||
signal.core.r4 | R4 | questionnaire-ccars-action-types | Questionnaire CCARS Action Types | draft | 1 | pa | us | ||
hl7.terminology | R5 | adverse-event-clinical-research-seriousness-criteria | Adverse Event Clinical Research Seriousness Criteria | active | 1 | brr | 2023-07 | uv | ncit |
de.netzwerk-universitaetsmedizin.ebm-cpg | R5 | vs-action-selection-behavior-required | Action Selection Behavior Required | draft | 2022-11 | uv | fhir | ||
hl7.terminology | R5 | v3-ActAdjudicationResultActionCode | ActAdjudicationResultActionCode | active | 2014-03 | uv | tho | ||
hl7.fhir.nl.zorgviewer | R3 | ACPTreatmentCodelist | ACP behandelingen waardelijst | active | 2025-07 | nl | sct | ||
hl7.fhir.uv.cpg | R4 | cpg-active-condition-vs | CPG Active Condition Value Set | active | cds | 2024-11 | uv | tho | |
fhir.cqf.common | R4 | active-condition | CQF Active Condition | active | 2019-07 | us | tho | ||
hl7.eu.fhir.pcsp | R4 | activeResolved-condition-vs | Active or resolved Condition | draft | 2025-07 | eu | tho | ||
ch.fhir.ig.ch-term | R4 | ActivePharmaceuticalIngredient | ActivePharmaceuticalIngredient | active | 2025-05 | ch | sct | ||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.13.3--20200901000000 | ActiviteitCodelijst | active | nl | oid | |||
hl7.fhir.us.vrdr | R4 | vrdr-activity-at-time-of-death-vs | Activity at Time of Death ValueSet | active | pher | 2024-10 | us | fhir tho | |
ch.fhir.ig.ch-epr-fhir | R4 | PpqmActorIdentifierType | CH PPQm Actor Identifier Type | active | 2025-05 | ch | ietf | ||
ch.fhir.ig.ch-epr-ppqm | R4 | PpqmActorIdentifierType | PPQm Actor Identifier Type | active | 2023-12 | ch | ietf | ||
hl7.fhir.us.nhsn-dqm | R4 | ach-encounter-class | Acute Care Hospital Encounter Class ValueSet | trial-use | 1 | pher | 2025-07 | us | tho |
hl7.fhir.us.nhsn-dqm | R4 | ach-encounter-status | Acute Care Hospital Encounter Status ValueSet | trial-use | 1 | pher | 2025-07 | us | fhir |
hl7.eu.fhir.pcsp | R4 | vs-Gvhd-acute-grade-eu-pcsp | Acute Gvhd Grade | draft | 2025-07 | eu | internal tho | ||
hl7.eu.fhir.pcsp | R4 | vs-Gvhd-chronic-grade-eu-pcsp | Chronic Gvhd condition | draft | 2025-07 | eu | internal tho | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.1.11.10416 | Financially Responsible Party Type Value Set | active | 2024-06 | us | tho | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.20 | Telecom Use (US Realm Header) | active | 2024-06 | us | tho | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.1.11.19579 | Family Member Value | active | 2024-06 | us | tho | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.38 | Smoking Status | active | 2024-06 | us | sct | ||
hl7.fhir.uv.tools | R5 | additional-binding-purpose | Additional Binding Purpose ValueSet | informative | 4 | fhir | 2025-07 | uv | fhir |
ch.fhir.ig.ch-term | R4 | condition-category | Condition Category Codes | active | 2025-05 | ch | |||
hl7.fhir.uv.cardx-cied | R5 | cied-connectivity-state-modifier-vs | CIED Connectivity Status Modifier Value Set | trial-use | 2 | cic | 2025-07 | uv | fhir |
ForgePatientChart.0830 | R4 | telus-address-state | TELUS ValueSet - Address State | draft | 2020-11 | ||||
hl7.fhir.us.davinci-crd | R4 | locationAddressType | CRD Location Address Types Value Set | trial-use | 4 | fm | 2025-07 | us | fhir |
ee.fhir.terminology | R5 | ads-adr-id | ADS AdrId | active | 2025-06 | ee | internal | ||
ee.fhir.terminology | R5 | ads-oid | ADS Oid | active | 2025-06 | ee | internal | ||
hl7.fhir.us.davinci-hrex | R4 | hrex-coverage-relationship | HRex Coverage Relationship ValueSet | draft | 0 | cic | 2025-04 | us | fhir tho |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.313 | Statin Allergen Grouping | active | 2024-03 | us | vsac | ||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.16.1--20200901000000 | AdemhalingScoreCodelijst | active | nl | loinc | |||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.12.3--20200901000000 | AdemhalingsreactieCodelijst | active | nl | oid | |||
hl7.fhir.uv.emedicinal-product-info | R5 | administrableDoseForm | Administrable Pharmaceutical Dose Form | active | 2025-07 | uv | fhir | ||
hl7.terminology | R5 | v3-AdministrationDetectedIssueCode | AdministrationDetectedIssueCode | active | 2014-03 | uv | tho | ||
ee.hl7.fhir.base.r5 | R5 | ee-administrative-gender | Administrative Gender | draft | 2023-08 | ee | fhir | ||
ee.fhir.terminology | R5 | administrative-gender | Administrative Gender | active | 2025-06 | ee | fhir | ||
ForgePatientChart.0830 | R4 | telus-administrative-gender | TELUS ValueSet - Administrative Gender | draft | 2020-11 | fhir | |||
fhir.kisumuhie | R4 | gender-vs | Gender | draft | 2025-06 | us | |||
fhir.kenyaPSIG | R4 | administrative-gender-vs | Administrative Gender | active | 2025-07 | us | fhir | ||
hl7.terminology | R5 | v3-xActEncounterReason | x_ActEncounterReason | active | 2014-03 | uv | tho | ||
ca.ab.fhir.psab | R4 | administrative-gender-ab | AdministrativeGender_AB | draft | 2024-06 | ca | tho | ||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.20.5.3--20200901000000 | AdresSoortCodelijst | active | nl | tho | |||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1235.645 | Pneumococcal Vaccine HD_CN_ Allergy | active | 2025-04 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1235.638 | b.well Adult Tetanus Vaccine CN | active | 2025-04 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1235.648 | bwell COVID Vaccine CN_Met | active | 2025-04 | us | vsac | ||
hl7.eu.fhir.idea4rc | R4 | adverse-event-type-eu-i4rc | Adverse Event Type | active | 2025-07 | eu | |||
hl7.eu.fhir.idea4rc | R4 | vs-affectedOrgan-eu-i4rc | Affected Organs (surgery) | active | 2025-07 | eu | fhir tho | ||
hl7.eu.fhir.pcsp | R4 | vs-affectedOrgan-eu-pcsp | Affected Organs (surgery) | draft | 2025-07 | eu | internal sct | ||
fhir.acme.affiliate-report | R4 | affiliate-type-vs | Affiliate Type ValueSet | draft | 2025-05 | us | internal | ||
hl7.fhir.us.registry-protocols | R4 | YesNo | Yes or No | active | cic | 2023-11 | us | sct tho | |
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.2--20200901000000 | AfnameprocedureCodelijst | active | nl | sct | |||
hl7.fhir.us.davinci-pdex | R4 | ProvenanceAgentType | Provenance Agent Type | informative | fm | 2025-06 | us | fhir tho | |
hl7.terminology | R5 | measure-aggregate-method | Measure Aggregate Method | active | cqi | 2023-02 | uv | tho | |
hl7.eu.fhir.idea4rc | R4 | alcoholUsageStatus-athena-eu-i4rc | Alcohol Usage Status: Athena | active | 2025-07 | eu | |||
hl7.eu.fhir.idea4rc | R4 | alcoholUsageStatus-snomed-eu-i4rc | Alcohol Usage Status: SNOMED CT | active | 2025-07 | eu | sct | ||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.7.3.2--20200901000000 | AlcoholGebruikStatusCodelijst | active | nl | sct tho | |||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.8.3.2--20200901000000 | AlertNaamCodelijst | active | nl | sct tho | |||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.8.3.1--20200901000000 | AlertTypeCodelijst | active | nl | loinc | |||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.12.1--20200901000000 | AlertheidCodelijst | active | nl | oid | |||
hl7.fhir.us.registry-protocols | R4 | StressTest | Cath PCI Selected Stress Test | active | cic | 2023-11 | us | loinc | |
fhir.cdc.opioid-cds-r4 | R4 | barbiturate-medications | Barbiturate Medications | active | 2025-02 | us | |||
fhir.cdc.opioid-cds-r4 | R4 | buprenorphine-and-methadone-medications | Buprenorphine and Methadone medications | active | 2023-05 | us |